US › Healthcare

Vincerx Pharma, Inc. Common Stock (VINC)

US · Healthcare · Biotechnology

$0.010.00%
Last close · 2026-08-04

Latest quarter · ended 2025-03-31

Revenue
$0
Net profit
$-5.0M
Profit YoY
+59.8%
EPS
$-3.57
EPS estimate
$-0.12

EPS came in at -3.57 against a street estimate of -0.12 — a miss of 2874.5%.

Key statistics

Market cap
$68,045
Forward P/E
0.0
P/B
0.03
Book value
$0.40
EPS (TTM)
$-5.79
52-week high
$0.07
52-week low
$0.00
50-day MA
$0.01
200-day MA
$0.01
Beta
1.40

Analyst view

Analysts rate Vincerx Pharma, Inc. Common Stock a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $200.00.

Shareholding

Insiders
4.12%
Institutions
5.25%

Largest institutional holders

FundStake
Bank & Trust Co0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Vincerx Pharma, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.